Lallemand Health Solutions and Proge Farm finalise a licensing deal for the commercialisation of L. plantarum P17630 (Proge P17630), a probiotic strain that addresses a number of women’s health conditions.
New recommendations that address the safety of biological products containing live microorganisms, may help firms obtain a marketing authorisation that is so far proving elusive, according to a research team
Australian brand Bioclinic Naturals has launched a range of ‘scobiotics’ – consisting prebiotics, probiotics, yeast, spirulina and enzymes – designed to address gastrointestinal problems ranging from inflammation to bringing homeostasis in the gut microflora.
Microbiotica is to contribute its reference genome database and culture collection of gut bacteria in a landmark study looking at the microbiome’s role in patients undergoing treatment for various cancers.
Dutch nutrition research and innovation firm Nutricia has announced it will support a series of research projects taking place around to world over the following weeks to help define nutrition guidelines to help speed up the recovery of COVID-19 patients.
Diabetic patients who adopt a nutrition therapy consisting of whey protein and monounsaturated fatty acids (MUFA) have lower fasting blood glucose during the one-month long Ramadan fasting period, a clinical trial in Malaysia has shown.
Nuritas once again harnesses Artificial Intelligence (AI) technology in the fight against the coronavirus as its platform is put to work identifying therapeutic peptides that modify the inflammatory response.
A curcumin and artemisinin-based oral spray has been proposed as a treatment for COVID-19 patients and a clinical trial will be conducted, ASX-listed phytocannabinoid firm MGC Pharmaceuticals has revealed.
Holland & Barrett staff have set up a petition, signed by thousands of staff and customers, begging the company to close its stores during the coronavirus pandemic as they argue their lives and the lives of customers are being put at risk.